Identifying gaps in vaccination perception after mandating the COVID-19 vaccine in Saudi Arabia

Vaccine. 2023 Jun 1;41(24):3611-3616. doi: 10.1016/j.vaccine.2023.04.057. Epub 2023 Apr 26.

Abstract

Objective: The burden of COVID-19 pandemic affected the globe, and it is unclear how it has impacted the general perception of other vaccines. We aimed to investigate the public awareness, knowledge, and attitude towards other complementary vaccines after the mandate of the COVID-19 vaccine.

Methods: A cross-sectional study was conducted in Saudi Arabia using a survey distributed via several social media platforms in June 2022. The questionnaire had three main sections; awareness; attitudes; and demographic information. Descriptive analysis was mainly used and supplemented with Chi-square test for correlation. All individuals over the age of 18 were eligible to participate in the study.

Results: A total of 1,045 participants from Saudi Arabia completed the survey. Of the respondents, 55.9% were female, and 95% were Saudi citizens. Public awareness towards vaccines after the mandate of COVID-19 vaccine was the highest with the influenza vaccine (98.2%), followed by human papillomavirus (HPV) (40.7%), tetanus, diphtheria, and pertussis (Tdap) (37.2%), and lastly, pneumococcal vaccine (17%). More than 50% of the participants expressed their willingness to receive any of the four vaccines if they knew about the benefits related to these vaccines.

Conclusion: The study showed that participants were willing to receive the vaccination if they were aware of the general benefits of vaccinations. Therefore, health education and campaigns toward recommended vaccines for high-risk group are essential and needed.

Keywords: Attitude; Awareness; COVID-19; Knowledge; Saudi Arabia; Vaccinations.

MeSH terms

  • Adult
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Cross-Sectional Studies
  • Female
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Influenza Vaccines*
  • Male
  • Middle Aged
  • Pandemics
  • Perception
  • Saudi Arabia
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Influenza Vaccines